PTCT

PTCT EBITDA Growth

-79.37%TTM

Period ending:

PTCT TTM EBITDA YoY %%
PTCT TTM EBITDA YoY %1161.65%-891.56%
2013-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

PTCT ebitda growth history

Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 51 observations from Dec 31, 2013 to Jun 30, 2026.

Ptc Therapeutics Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-79.3744%
-102.5617%
836.8769%
962.9478%
736.6518%
430.4085%
63.5335%
75.1154%
68.544%
29.5602%
10.1805%
-25.3427%
-16.0404%
-4.5675%
0.1097%
-14.4744%
-67.9604%
-14.5727%
-21.4771%
10.1027%
40.7854%
-31.1504%
-56.1764%
-103.2058%
-138.0828%
-89.6531%
-179.1396%
-314.2094%
-692.8638%
-283.0104%
-49.1547%
52.0112%
79.075%
72.8216%
63.6077%
46.3831%
43.1936%
29.3036%
22.022%
-2.326%
-20.9433%
-35.8873%
-69.0256%
-78.9679%
-124.9421%
-148.567%
-125.9825%
-168.8339%
-77.5966%
-96.5142%
-92.9097%

Compare ebitda growth

All PTCT financial metrics · PTCT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.